Mumbai: The COVID-19 vaccine, co-developed by the University of Oxford and drug manufacturer AstraZeneca, is likely to get emergency use approval first in India, a report has claimed.
Quoting unnamed “official sources”, PTI has reported that the vaccine would be approved here after the United Kingdom gives a go-ahead. The Indian drug regulator is looking at the UK, which sources believe may give its nod to the Oxford Covid-19 vaccine next week.
The vaccine known as Covishield is being manufactured by the Pune-based Serum Institute of India.
“Once the UK drug regulator gives its approval to the Oxford vaccine, the expert committee on COVID-19 at the CDSCO will hold its meeting and thoroughly review the safety and immunogenicity data from the clinical evaluations conducted abroad and in India before granting any emergency authorisation for the vaccine here,” PTI said quoting unnamed official sources.
The emergency approvals for Bharat BioTech’s Covaxin will take time as it is still in Phase 3 trials.
Also Read: Pork Among Ingredients? Muslim Clerics Raise Concern Over Vaccine
New Delhi: The BJP-led NDA government will introduce 15 bills, including one to amend the…
Bhubaneswar: A newborn baby, who was allegedly sold by her parents in Odisha's Balangir district,…
Mumbai: Exit polls have given Bharatiya Janata Party-led Mahayuti alliance an edge in the neck-to-neck…
Cuttack: The Orissa High Court has put the BDA's order for demolition of controversial Shree…
New York: Amid reports of deteriorating health of astronauts Sunita Williams and Butch Wilmore, it…
Mumbai: South superstar Prabhas has surpassed Bollywood King Khan Shah Rukh and ‘Dabangg’ Salman Khan…
Jajpur: Police on Thursday arrested 10 persons in connection with the alleged attack on MLA…
Bhawanipatna: Five year after the rape of a woman, Dharamgarh Additional District and Session court…